论文部分内容阅读
“上海市公费医疗、劳保医疗人员药品报销范围”第五次修订方案经过药品生产企业的申请和上海市卫生局、医疗保险局按规定程序组织相关医学、药学专家对申报的药品进行严格评审,并对现有列入报销范围的药品进行甄别以后,日前上海市卫生局、医疗保险局、财政局和劳动局已联合发出通知,公布了共同研究的结果。 本次修订增列至报销范围的有77个药品,同时有23个品种增加了商品名,17个药品扩大了临床使用范围,8个
The fifth revised plan of “Scope of Drug Reimbursement for Shanghai Public Expendable Medical and Labor Insurance Medical Staff” has undergone a rigorous review by the pharmaceutical production enterprises and the Shanghai Municipal Bureau of Health and the Medical Insurance Bureau organized related medical and pharmacy experts to make a rigorous assessment of the declared drugs. After screening the existing drugs that are included in the scope of reimbursement, the Shanghai Municipal Health Bureau, the Medical Insurance Bureau, the Finance Bureau, and the Labor Bureau have jointly issued a notice and announced the results of the joint study. There are 77 drugs added to the scope of reimbursement for this revision, 23 varieties have added brand names, 17 drugs have expanded the scope of clinical use, 8